The new esophageal atresia clinic is dedicated to the long-term treatment of children with EA-TEF. The clinic provides coordinated multidisciplinary care that addresses all facets of their patients’ conditions.
Breaking news in the treatment of gastroesophageal reflux disease (GERD): NYP/Columbia now offers an incisionless alternative to continuous medications or open surgical procedures for patients suffering from severe reflux disease.
Marc Bessler, MD, Director, Minimal Access Surgery Center, and his colleagues at Columbia University Medical Center are using, testing, and refining three new methods of performing surgery that leave no external scars on the body.
Esophageal cancer rates have risen 600% since 1975, with the American Cancer Society predicting that 15,560 people will be diagnosed with esophageal cancer in 2007. To address this crucial public health need, physicians at NewYork-Presbyterian Hospital have collaborated to create the new Esophageal Disorders Program.